BridgeMD
New treatment option for Persistent Post Concussion Syndrome
Official title Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms
ClinicalTrials.gov ID: NCT07246993
What this study is testing
- What it's testing
- This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at improving function in individuals suffering from persistent post-concussive syndrome (PPCS) following mild traumatic brain injury (mTBI).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age 18-65
- Has sustained a single mTBI 3-12 months prior to enrollment
- Meets criteria for PPCS (assessed using the CP Screen)
- Has reliable access to a smartphone
You likely can't join if
- Inability to provide informed consent or complete study procedures
- History of moderate/severe TBI
- Significant neurological or psychiatric disorders (other than PPCS-related symptoms like mild depression/anxiety)
- Substance dependence within the last six months
- Contraindications to tDCS (e.g., implanted metal, skin lesions on scalp)
The study team makes the final eligibility decision.
Where it's taking place
- Minneapolis, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Minneapolis, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.